Key Points
The human gastrointestinal tract harbors a vast ensemble of microbes representing over 500 different species. In a healthy state, a fine balance exists between the populations of health-promoting and potentially harmful bacteria. Gut microflora plays an important role in the development, maturation and functioning of the immune system. Disruptions in the intestinal homeostasis result in increased susceptibility to infectious diseases, cancers and immunoinflammatory disorders. Many factors such as enteric infections, intake of antibiotics and stress could disturb the intestinal microbial homeostasis. Intake of probiotic organisms have been shown to restore/optimize gut microbial balance and promote health and well-being. Lactobacilli and bifidobacteria are commonly used as probiotics. Specific strains of probiotics are able to modulate the functioning of the immune system in health and disease. Probiotics enhance immune function in healthy individuals, but down-regulate dysfunctional immune responses in subjects suffering from immunoinflammatory disorders such as allergies and inflammatory bowel diseases. Probiotic-induced immune stimulation is associated with increased protection against intestinal and extra-intestinal infections and cancers, and improved efficacy of vaccines. The mechanisms by which probiotics mediate their disparate immunological effects in health and disease are not fully understood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gilmore MS, Ferretti JJ (2003) Microbiology. The thin line between gut commensal and pathogen. Science 299:1999–2002
McCracken VJ, Lorenz RG (2001) The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol 3:1–11
Macfarlane S, Macfarlane GT (2004) Bacterial diversity in the human gut. Adv Appl Microbiol 54:261–289
Kimura K, McCartney AL, McConnell MA, Tannock GW (1997) Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains. Appl Environ Microbiol 63:3394–3398
Fooks LJ, Gibson GR (2002) Probiotics as modulators of the gut flora. Br J Nutr 88(Suppl 1):S39–S49
Satokari RM, Vaughan EE, Akkermans ADL, Saarela M, de Vos WM (2001) Polymerase chain reaction and denaturing gel electrophoresis monitering of fecal Bifidobacterium populations in prebiotics and probiotics feeding trial. Syst Appl Microbiol 24:227–231
Tannock GW, Munro K, Harmsen HJM, Welling GW, Smart J, Gopal PK (2000) Analysis of the fecal microflora of human subjects consuming a probiotic containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 66:2578–2588
FAO/WHO (2002) Guidelines for the evaluation of probiotics in food. Report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. London, ON, Canada
Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in’t Veld JHJ (1998) Overview of gut flora and probiotics. Int J Food Microbiol 41:85–101
Guarner F, Malagelada J-R (2003) Gut flora in health and disease. Lancet 361:512–519
Gill HS (2003) Probiotics to enhance anti-infective defenses in the gastrointestinal tract. Best Pract Res Clin Gastroenterol 17:755–773
Gill HS, Rutherfurd KJ (2001) Probiotic supplementation to enhance natural immunity in the elderly. Effect of a newly characterized immunostimulatory strain Lactobacillus rhamnosus HN001 (DR20TM) on leucocytes phagocytosis. Nutr Res 21:183–189
Kelly D, Conway S (2001) Genomics at work: the global gene response to enteric bacteria. Gut 49:612–613
Fukushima K, Ogawa H, Takahashi K, Naito H, Funayama Y, Kitayama T, Yonezawa H, Sasaki I (2003) Non-pathogenic bacteria modulate colonic epithelial gene expression in germ-free mice. Scand J Gastroenterol 38:626–634
Ogawa H, Fukushima K, Sasaki I, Matsuno S (2000) Identification of genes involved in mucosal defense and inflammation associated with normal enteric bacteria. Am J Physiol Gastrointest Liver Physiol 279:G492–G499
Hooper LV, Gordon JI (2001) Commensal host-bacterial relationships in the gut. Science 292:1115–1118
Vaughan EE, Schut F, Heilig HG, Zoetendal EG, de Vos WM, Akkermans AD (2000) A molecular view of the intestinal ecosystem. Curr Issues Intest Microbiol 1:1–12
Wostmann BS (1996) Germfree and gnotobiotic animal models: background and applications. CRC, Boca Raton, FL
Spencer JP (2003) Metabolism of tea flavonoids in the gastrointestinal tract. J Nutr 133:3255S–3261S
Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, Cassidy A (2003) Bioavailability of phyto-oestrogens. Br J Nutr 89:S45–S58
Turner NJ, Thomson BM, Shaw IC (2003) Bioactive isoflavones in functional foods: the importance of gut microflora on bioavailability. Nutr Rev 61:204–213
Blaut M (2002) Relationship of prebiotics and food to intestinal microflora. Eur J Nutr 41:I11–I16
Mutch DM, Simmering R, Donnicola D, Fotopoulos G, Holzwarth JA, Williamson G, Irene Corthesy-Theulaz I (2004) Impact of commensal microbiota on murine gastrointestinal tract gene ontologies. Physiol Genomics 19:22–31
Cummings JH, Antoine JM, Azpiroz F, Bourdet-Sicard R, Brandtzaeg P, Calder PC, Gibson GR, Guarner F, Isolauri E, Pannemans D, Shortt C, Tuijtelaars S, Watzl B (2004) PASSCLAIM-gut health and immunity. Eur J Nutr 43(Suppl 2):118–173
Beutler B, Rietschel ET (2003) Timeline: innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3:169–176
Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1:135–145
Nagler-Anderson C (2001) Man in the barrier! Strategic defenses in the intestinal mucosa. Nat Rev Immunol 1:59–67
Ricciardi-Castagnoli P, Granucci F (2002) Opinion: interpretation of the complexity of innate immune responses by functional genomics. Nat Rev Immunol 2:881–889
Devereux G (2002) The immune system: an overview. In: Calder PC, Field CJ, Gill HS (eds) Nutrition and immune function. CAB International Publishing, Oxon, UK, pp 1–20
Hoebe K, Janssen E, Beutler B (2004) The interface between innate and adaptive immunity. Nat Immunol 5:971–974
Haddad PS, Azar GA, Groom S, Boivin M (2005) Natural health products, modulation of immune function and prevention of chronic diseases. Adv Access Publ 2:513–520
Roitt I, Brostoff J, Male D (1998) Immunology, 5th edn. Mosby, London, UK, p. 423
Meyers RA (2007) Immunology from cell biology to disease. Wiley-VCH Verlag GmbH & Co, Weinheim, Germany
Kelso A, Troutt AB, Maraskovsky E, Gough NM, Morris L, Pech MH, Thomson JA (1991) Heterogeneity in lymphokine profiles of CD4+ and CD8+ T cells and clones activated in vivo and in vitro. Immunol Rev 123:85–114
Ley K, Smith E, Stark MA (2006) IL-17A-producing neutrophil-regulatory Tn lymphocytes. Immunol Res 34:229–242
Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24:677–688
Bettelli E, Oukka M, Kuchroo VK (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345–350
Deenick EK, Tangye SG (2007) Autoimmunity: IL-21: a new player in Th17-cell differentiation. Immunol Cell Biol 85:503–505
Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV, Rook GA (2006) Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 3:275–284
Hofer T, Nathansen H, Lohning M, Radbruch A, Heinrich R (2002) GATA-3 transcriptional imprinting in Th2 lymphocytes: a mathematical model. Proc Natl Acad Sci USA 99:9364–9368
van den Ham H-J, de Boer RJ (2008) From the two-dimensional Th1 and Th2 phenotypes to high-dimensional models for gene regulation. Int Immunol 20:1269–1277
Murphy KM, Reiner SL (2002) The lineage decisions of helper T cells. Nat Rev Immunol 2:933–944
Leonard WJ (2003) Type I cytokines and interferons and their receptors. In: Paul WE (ed) Fundamental immunology. Lippincott Williams & Wilkins, Philadelphia, USA, pp 701–747
Macpherson AJ, Harris NL (2004) Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4:478–485
Spiekermann GM, Walker WA (2001) Oral tolerance and its role in clinical disease. J Pediatr Gastroenterol Nutr 32:237–255
Helgeland L, Brandtzaeg P (2000) Development and function of intestinal B and T cells. Microbiol Ecol Health Dis 12:110–127
Lefrancois L, Puddington L (2006) Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo. Annu Rev Immunol 24:681–704
Macdonald TT, Monteleone G (2005) Immunity, inflammation, and allergy in the gut. Science 307:1920–1925
Mestecky J, Blumberg RS, Kiyono H, McGhee JR (2003) The mucosal immune system. In: Paul WE (ed) Fundamental immunology. Lippincott Williams & Wilkins, Philadelphia, PA, pp 965–1021
Mowat AM (2003) Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 3:331–341
MacDonald TT, Monteleone G, Pender SL (2000) Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 51:2–9
Korzenik JR, Podolsky DK (2006) Evolving knowledge and therapy of inflammatory bowel disease. Nat Rev Drug Discov 5:197–209
Strober W, Fuss IJ, Blumberg RS (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol 20:495–549
Brandtzaeg P, Farstad IN, Johansen FE, Morton HC, Norderhaug IN, Yamanaka T (1999) The B-cell system of human mocosae and exocrine glands. Immunol Rev 171:45–87
Haller D, Bode C, Hammes WP, Pfeifer AM, Schiffrin EJ, Blum S (2000) Nonpathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47:79–87
Claassen E, Van Winsen R, Posno M, Boersma WJ (1995) New and safe “oral” live vaccines based on lactobacillus. Adv Exp Med Biol 371:1553–1558
Muscettola M, Massai L, Tanganelli C, Grasso G (1994) Effects of lactobacilli on interferon production in young and aged mice. Ann N Y Acad Sci 717:226–232
Galdeano CM, Perdigon G (2004) Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J Appl Microbiol 97:673–681
Lammers KM, Helwig U, Swennen E, Rizzello F, Venturi A, Caramelli E, Kamm MA, Brigidi P, Gionchetti P, Campieri M (2002) Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol 97:1182–1186
Otte JM, Podolsky DK (2004) Functional modulation of enterocytes by gram-positive and gramnegative microorganisms. Am J Physiol Gastrointest Liver Physiol 286:613–626
McCracken VJ, Chun T, Baldeon ME, Ahrne S, Molin G, Mackie RI, Gaskins HR (2002) TNF alpha sensitizes HT-29 colonic epithelial cells to intestinal lactobacilli. Exp Biol Med 227:665–670
Zhang L, Li N, Caicedo R, Neu J (2005) Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr 135:1752–1756
Ma D, Forsythe P, Bienenstock J (2004) Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 72:5308–5314
Ruiz PA, Hoffmann M, Szcesny S, Blaut M, Haller D (2005) Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology 115:441–450
Vinderola G, Matar C, Perdigon G (2005) Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors. Clin Diagn Lab Immunol 12:1075–1084
Ogawa T, Asai Y, Tamai R, Makimura Y, Sakamoto H, Hashikawa S, Yasuda K (2006) Natural killer cell activities of synbiotic Lactobacillus casei ssp. casei in conjunction with dextran. Clin Exp Immunol 143:103–109
Tien MT, Girardin SE, Regnault B, Le Bourhis L, Dillies MA, Coppee JY, Bourdet-Sicard R, Sansonetti PJ, Pedron T (2006) Antiinflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 176:1228–1237
Delneste Y, Donnet-Hughes A, Schiffrin EJ (1998) Functional foods: mechanisms of action on immunocompetent cells. Nutr Rev 56:S93–S98
Yan F, Polk DB (2002) Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 277:50959–50965
Perdigon G, de Macias ME, Alvarez S, Oliver G, de Ruiz Holgado AP (1988) Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology 63:17–23
Gill HS, Rutherfurd KJ, Prasad J, Gopal PK (2000) Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr 83:167–176
Schiffrin EJ (1994) Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78:491–497
Schiffrin EJ, Brassart D, Servin AL, Rochat F, Donnet-Hughes A (1997) Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 66:515S–520S
Donnet-Hughes A, Rochat F, Serrant P, Aeschlimann JM, Schiffrin EJ (1999) Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. J Dairy Sci 82:863–869
Arunachalam K, Gill HS, Chandra RK (2000) Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr 54:263–267
Gill HS, Rutherfurd KJ, Cross ML (2001) Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol 21:264–271
Gill HS, Rutherfurd KJ, Cross ML, Gopal PK (2001) Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74:833–839
Pelto L, Isolauri E, Lilius EM, Nuutila J, Salminen S (1998) Probiotic bacteria down-regulate the milk-induced inflammatory response in milk hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin Exp Allergy 28:1474–1479
Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS (2001) Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr 20:149–156
Takeda K, Suzuki T, Shimada SI, Shida K, Nanno M, Okumura K (2006) Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol 146:109–115
Olivares M, Diaz-Ropero MP, Sierra S, Lara-Villoslada F, Fonolla J, Navas M, Rodriguez JM, Xaus J (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23:254–260
Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM (1994) Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 10:55–63
Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T (1995) Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13:310–312
Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T (1995) Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child 72:51–53
Majamaa H, Isolauri E, Saxelin M, Vesikari T (1995) Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 20:333–338
Fukushima Y, Kawata Y, Hara H, Terada A, Mitsuoka T (1998) Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 42:39–44
Park JH, Um JI, Lee BJ, Goh JS, Park SY, Kim WS, Kim PH (2002) Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production. Cell Immunol 219:22–27
Leblanc J, Fliss I, Matar C (2004) Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk. Clin Diagn Lab Immunol 11:1171–1181
Ibnou-Zekri N, Blum S, Schiffrin EJ, von der Weid T (2003) Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun 71:428–436
Rinne M, Kalliomaki M, Arvilommi H, Salminen S, Isolauri E (2005) Effect of probiotics and breastfeeding on the Bifidobacterium and Lactobacillus/Enterococcus microbiota and humoral immune responses. J Pediatr 147:186–191
Alberda C, Gramlich L, Meddings J, Field C, McCargar L, Kutsogiannis D, Fedorak R, Madsen K (2007) Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 85:816–823
Moser M (2003) Dendritic cells. In: Paul WE (ed) Fundamental immunology. Lippincott Williams & Wilkins, Philadelphia, PA, pp 455–480
Braat H, van den Brande J, van Tol E, Hommes D, Peppelenbosch M, van Deventer S (2004) Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. Am J Clin Nutr 80:1618–1625
Christensen HR, Frokiaer H, Pestka JJ (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 168:171–178
Drakes M, Blanchard T, Czinn S (2004) Bacterial probiotic modulation of dendritic cells. Infect Immun 72:3299–3309
Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, Gionchetti P, Campieri M, Kamm MA, Knight SC, Stagg AJ (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53:1602–1609
Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TMM, Zaat BAJ, Yazdanbakhsh M, Wierenga EA, van Kooyk Y, Kapsenberg ML (2005) Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 115:1260–1267
Di Giacinto C, Marinaro M, Sanchez M, Strober W, Monica Boirivant M (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β bearing regulatory cells. J Immunol 174(6):3237–3246
von der Weid T, Bulliard C, Schiffrin EJ (2001) Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin Diagn Lab Immunol 8:695–701
Prioult G, Fliss I, Pecquet S (2003) Effect of probiotic bacteria on induction and maintenance of oral tolerance to beta-lactoglobulin in gnotobiotic mice. Clin Diagn Lab Immunol 10:787–792
Prioult G, Pecquet S, Fliss I (2004) Stimulation of interleukin-10 production by acidic beta lactoglobulin-derived peptides hydrolyzed with Lactobacillus paracasei NCC2461 peptidases. Clin Diagn Lab Immunol 11:266–271
Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, Bavari S, Klaenhammer TR (2005) Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA 102:2880–2885
Delcenserie V, Martel D, Lamoureux M, Amiot J, Boutin Y, Roy D (2008) Immunomodulatory effects of probiotics in the intestinal. Curr Issues Mol Biol 10:37–54
Van Eden E, van der Zee R, van Kooten P, Berlo SE, Cobelens PM, Kavelaars A, Heijnen CJ, Prakken B, Roord S, Albani S (2002) Balancing the immune system: Th1 and Th2. Ann Rheum Dis 61(Suppl II):25–28
Liew FY (2002) TH1 and TH2 cells: a historical perspective. Nat Rev Immunol 2:55–60
Kidd P (2003) Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8:223–246
Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737–742
Shevach EM (2000) Suppressor T cells: rebirth, function and homeostasis. Curr Biol 10:572–575
Pochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, Mercenier A (2002) Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 110:617–623
Shida K, Takahashi R, Iwadate E, Takamizawa K, Yasui H, Sato T, Habu S, Hachimura S, Kaminogawa S (2002) Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin Exp Allergy 32:563–570
Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O, Savilahti E (2004) Lactobacillus GG effect in increasing IFN-gamma production in infants with cow’s milk allergy. J Allergy Clin Immunol 114:131–136
Sutas Y, Hurme M, Isolauri E (1996) Downregulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG derived enzymes. Scand J Immunol 43:687–689
Kishi A, Uno K, Matsubara Y, Okuda C, Kishida T (1996) Effect of the oral administration of Lactobacillus brevis subsp. coagulans on interferon-alpha producing capacity in humans. J Am Coll Nutr 15:408–412
Miettinen M, Matikainen S, Vuopio-Varkila J, Pirhonen J, Varkila K, Kurimoto M, Julkunen I (1998) Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun 66:6058–6062
Pessi T, Sutas Y, Saxelin M, Kallioinen H, Isolauri E (1999) Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl Environ Microbiol 65:4725–4728
Amrouche T, Boutin Y, Prioult G, Fliss I (2006) Effects of bifidobacterial cytoplasm, cell wall and exopolysaccharide on mouse lymphocyte proliferation and cytokine production. Int Dairy J 16:70–80
Maassen CB, van Holten-Neelen C, Balk F, den Bak-Glashouwer MJ, Leer RJ, Laman JD, Boersma WJ, Claassen E (2000) Strain dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 18:2613–2623
Perdigon G, Maldonado Galdeano C, Valdez JC, Medici M (2002) Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 56(Suppl 4):S21–S26
Miettinen M, Vuopio-Varkila J, Varkila K (1996) Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 64:5403–5405
Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765
Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263–274
Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN (1999) Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116:1107–1114
McCarthy J, O’Mahony L, O’Callaghan L, Sheil B, Vaughan EE, Fitzsimons N, Fitzgibbon J, O’Sullivan GC, Kiely B, Collins JK, Shanahan F (2003) Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52:975–980
O’Mahony L, Feeney M, O’Halloran S, Murphy L, Kiely B, Fitzgibbon J, Lee G, O’Sullivan G, Shanahan F, Collins JK (2001) Probiotic impact on microbial flora, inflammation and tumor development in IL-10 knockout mice. Aliment Pharmacol Ther 15:1219–1225
Sheil B, McCarthy J, O’Mahony L, Bennett MW, Ryan P, Fitzgibbon JJ, Kiely B, Collins JK, Shanahan F (2004) Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 53:694–700
Pena JA, Rogers AB, Ge Z, Ng V, Li SY, Fox JG, Versalovic J (2005) Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun 73:912–920
Majamaa H, Isolauri E (1997) Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 99:179–185
Borruel N, Carol M, Casellas F, Antolin M, de Lara F, Espin E, Naval J, Guarner F, Malagelada JR (2002) Increased mucosal tumor necrosis factor alpha production in Crohn’s disease can be downregulated ex vivo by probiotic bacteria. Gut 51:659–664
Carol M, Borruel N, Antolin M, Llopis M, Casellas F, Guarner F, Malagelada JR (2006) Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn’s disease. J Leukoc Biol 79:917–922
Pena JA, Li SY, Wilson PH, Thibodeau SA, Szary AJ, Versalovic J (2004) Genotypic and phenotypic studies of murine intestinal lactobacilli: species differences in mice with and without colitis. Appl Environ Microbiol 70:558–568
Kato I, Endo-Tanaka K, Yokokura T (1998) Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice. Life Sci 63:635–644
Maassen CB, van Holten JC, Balk F, Heijne den Bak-Glashouwer MJ, Leer R, Laman JD, Boersma WJ, Claassen E (1998) Orally administered Lactobacillus strains differentially affect the direction and efficacy of the immune response. Vet Q 20(Suppl 3):S81–S83
Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T, Saxelin M, Vapaatalo H, Moilanen E, Korpela R (2003) Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis pilot study. Scand J Rheumatol 32:211–215
Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, Purdie G, Crane J (2008) A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 122:788–794
Prescott SL, Wickens K, Westcott L, Jung W, Currie H, Black PN, Stanley TV et al (2008) Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-γ and breast milk transforming growth factor-β and immunoglobin A detection. Clin Exp Allergy 38:1606–1614
Roessler A, Friedrich U, Vogelsang H, Bauer A, Kaatz M, Hipler UC, Schmidt I, Jahreis G (2008) The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention. Clin Exp Allergy 38:93–102
Odamaki T, Xiao J-Z, Iwabuchi N, Sakamoto M, Takahashi N, Kondo S, Kazuhiro Miyaji K, Iwatsuki K, Togashi H, Enomoto T, Benno Y (2007) Influence of Bifidobacterium longum BB536 intake on faecal microbiota in individuals with Japanese cedar pollinosis during the pollen season. J Med Microbiol 56:1301–1308
Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, Dewulf J, Pot B, Thomas Hartung T, Hols P, Mercenier A (2005) Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci USA 102:10321–10326
Hessle C, Andersson B, Agnes E, World AE (2000) Infect Immun 68:3581–3586
Lammers KM, Brigidi P, Vitali B, Gionchetti P, Rizzello F, Caramelli E, Matteuzzi D, Campieri M (2003) Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 38:165–172
Ivec M, Botic T, Koren S, Jakobsen M, Weingartl H, Cencic A (2007) Interactions of macrophages with probiotic bacteria lead to increased antiviral response against vesicular stomatitis virus. Antiviral Res 75:266–274
Cross ML, Ganner A, Teilab D, Fray LM (2004) Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria. FEMS Immunol Med Microbiol 42:173–180
Nerstedt A, Nilsson EC, Ohlson K, Håkansson J, Thomas Svensson L, Löwenadler B, Svensson UK, Mahlapuu M (2007) Administration of Lactobacillus evokes coordinated changes in the intestinal expression profile of genes regulating energy homeostasis and immune phenotype in mice. Br J Nutr 97:1117–1127
Nonaka Y, Izumo T, Izumi F, Maekawa T, Shibata H, Nakano A, Kishi A, Akatani K, Kiso Y (2008) Antiallergic effects of Lactobacillus pentosus strain S-PT84 mediated by modulation of Th1/Th2 immunobalance and induction of IL-10 production. Int Arch Allergy Immunol 145:249–257
Carroll IM, Andrus JM, Bruno-Bárcena JM, Klaenhammer TR, Hassan HM, Threadgill DS (2007) Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 293:G729–G738
Bujalance C, Moreno E, Jimenez-Valera M, Ruiz-Bravo A (2007) A probiotic strain of Lactobacillus plantarum stimulates lymphocyte responses in immunologically intact and immunocompromized mice. Int J Food Microbiol 113:28–34
Aguero G, Villena J, Racedo S, Haro C, Alvarez S (2006) Beneficial immunomodulatory activity of Lactobacillus casei in malnourished mice pneumonia: effect on inflammation and coagulation. Nutrition 22:810–819
Shima T, Fukushima K, Setoyama H, Imaoka A, Matsumoto S, Hara T, Suda K, Umesaki Y (2008) Differential effects of two probiotic strains with different bacteriological properties on intestinal gene expression, with special reference to indigenous bacteria. FEMS Immunol Med Microbiol 52:69–77
Kaburagi T, Yamano T, Fukushima Y, Yoshino H, Mito N, Sato K (2007) Effect of Lactobacillus johnsonii La1 on immune function and serum albumin in aged and malnourished aged mice. Nutrition 23:342–350
Vidal K, Benyacoub J, Moser M, Sanchez-Garcia J, Serrant P, Segura-Roggero I, Reuteler G, Blum S (2008) Effect of Lactobacillus paracasei NCC2461 on antigen-specific T-cell mediated immune responses in aged mice. Rejuvenation Res 11:957–964
Shimada T, Cheng L, Shi HB, Hayashi A, Motonaga C, Tang J, Enomoto K, Enomoto T (2007) Effect of lysed Enterococcus faecalis FK-23 on allergen-induced immune responses and intestinal microflora in antibiotic-treated weaning mice. J Invest Allergy Clin Immunol 17:70–76
Duncker SC, Lorentz A, Schroeder B, Breves G, Bischoff SC (2006) Effect of orally administered probiotic E. coli strain Nissle 1917 on intestinal mucosal immune cells of healthy young pigs. Vet Immunol Immunopathol 111:239–250
Paturi G, Phillips M, Kailasapathy K (2008) Effect of probiotic strains Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 on systemic immune functions and bacterial translocation in mice. J Food Prot 71:796–801
Chiang BL, Sheih YH, Wang LH, Gill HS (2000) Enhancement of immunity by Bifidobacterium lactis: optimisation and definition of cellular responses. Eur J Clin Nutr 54:849–855
Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30:1604–1610
Rautava S, Kalliomäki M, Isolauri E (2002) Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 109:119–121
Viljanen M, Pohjavuori E, Haahtela T, Korpela R, Kuitunen M, Sarnesto A, Vaarala O, Savilahti E (2005) Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J Allergy Clin Immunol 115:1254–1259
Ishida Y, Nakamura F, Kanazto H, Sawada D, Yamamoto N, Kagata H et al (2005) Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial. Biosci Biotechnol Biochem 69:1652–1660
Morita H, He F, Kawase M, Kubota A, Hiramatsu M, Kurisaki JI, Salminen S (2006) Preliminary human study for possible alteration of serum immunoglobulin E production in perennial allergic rhinitis with fermented milk prepared with Lactobacillus gasseri TMC0356. Microbiol Immunol 50:701–706
Mastrandrea F (2004) Probiotics reduce the CD34+ hemopoietic precursor cell increased traffic in allergic subjects. Eur Ann Allergy Clin Immunol 36:118–122
Olivares M, Díaz-Ropero M, Gómez N, Sierra S, Lara-Villoslada F, Martín R, Rodriguez JM, Xaus J (2006) Dietary deprivation of fermented foods causes a fall in innate immune response. Lactic acid bacteria can counteract the immunological effect of this deprivation. J Dairy Res 73:492–498
Flinterman AE, Knol EF, van leperen-van Dijk AG, Timmerman HM, Knulst AC, Bruijnzeel-Koomen CAFM, Pasmans SGMA, van Hoffen E (2007) Probiotics have a different immunomodulatory potential in vitro versus ex vivo upon oral administration in children with food allergy. Int Arch Allergy Immunol 143:237–244
Marschan E, Kuitunen M, Kukkonen K, Poussa T, Sarnesto A, Haahtela T, Korpela R, Savilahti E, Vaarala O (2008) Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 38:611–618
Marschan E, Honkanen J, Kukkonen K, Kuitunen M, Savilahti E, Vaarala O (2008) Increased activation of GATA-3, IL-2 and IL-5 of cord blood mononuclear cells in infants with IgE sensitization. Pediatr Allergy Immunol 19:132–139
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Donkor, O.N., Vasiljevic, T., Gill, H.S. (2010). Probiotics and Immunomodulation. In: Watson, R., Zibadi, S., Preedy, V. (eds) Dietary Components and Immune Function. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-061-8_34
Download citation
DOI: https://doi.org/10.1007/978-1-60761-061-8_34
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-060-1
Online ISBN: 978-1-60761-061-8
eBook Packages: MedicineMedicine (R0)